Various murine cell populations were tested for their ability to generate interleukin-6 (IL-6) in response to IL-3. Among these, bone marrow cells exhibit the most prominent IL-6 production. The responder cells in this organ have been further characterized by cell fractionation on a discontinuous Ficoll gradient, fluorescence-activated cell sorting, and in situ hybridization. These procedures have allowed us to ascribe the following features to the cells mainly responsible for IL-3-induced IL-6 production: (1) they possess a low density and a relatively high forward and perpendicular light scatter (FLWPLS); (2) they are characterized by a high rhodamine (Rh) retention; and (3) their enrichment in various subpopulations is similar to that obtained for progenitors forming colonies in the methylcellulose assay colony-forming units (CFU-C). In contrast, IL-3 target cells in terms of IL-6 produc-NTERLEUKIN-6 (IL-6) is a particularly pleiotropic
I cytokine whose wide spectrum of biologic activities has resulted in a number of different designations, such as interferon Pz,' B-cell stimulatory factor 2,2 hybridoma growth factory and hepatocyte-stimulating factor? Furthermore, it has been characterized as a macrophage-granulocyte differentiation inducer, termed MGI-2. 6 The multiple biologic effects of IL-6 range from regulation of acute phase protein synthesis by hepatocytes7 over induction of cell differentiation8,' and expression of differentiated cell functions.''."
Considering the increasing evidence for an important regulatory function of IL-6 during hematopoiesis,".l6 the present study was performed to identify the cells that generate this factor in the bone marrow in response to the hematopoietic growth factor IL-3. In particular, we have examined if progenitor cells could be involved in this phenomenon. Indeed, until now, IL-6 production in mouse has been mainly ascribed to stimulated stromal cells, macrophages, and T-helper cells,17 excepting a report by Lotem et al showing that bone marrow cells enriched for myeloid precursors can be induced to produce this cytokine in response to different colony-stimulating factors."
In view of these observations, we have taken advantage of the recent progress in fluorescence-activated stem cell sorting and in situ hybridization to define more precisely the bone marrow cell population that responds to IL-3 by enhanced IL-6 production. This study was achieved by analyzing their light scatter their rhodamine (Rh) retention," and their morphology after labeling with the IL-6 messenger RNA (mRNA) probe. mesenteric lymph node cell suspensions were obtained, as previously described," by disrupting the organs in a Potter Elvehjem homogenizer. Spleen cells were suspended in HBSS by gently teasing with forceps. Finally, peritoneal cells were removed from the peritoneal cavity by repeated washing with HBSS, containing 10 IUimL heparin (Liquemin Roche, Paris, France). All cell suspensions were centrifuged and adjusted, unless otherwise stated, to a final concentration of 5 x lo6 nucleated cellsimL for bone marrow, spleen, lymph node cells, and thymocytes. Peritoneal macrophages, at a final concentration of 106imL, were obtained after a 4-hour adherence at 37°C in flat-bottomed 24-well culture plates (Falcon 3047; Falcon Plastics, Oxnard, CA), followed by repeated washing with HBSS. Bone marrow cells for the set up of stromal layers and cell sorting experiments were prepared as described beforez3 by cleaning femurs and tibias from muscles and tendons and grinding them in a mortar using phosphate-buffered saline (PBS). The cell suspensions were sieved over a nylon filter (mesh size, 100 km). When not otherwise stated, cells were cultured in serum-free minimum essential medium with Earle's salts (GIBCO) supplemented with 1% sodium pyruvate lOOX
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(GIBCO), 1% L-glutamine (GIBCO), 100 IU/mL penicillin, and 100 pg/mL streptomycin. They were incubated for different periods in culture tubes (Falcon 2003) or microtiter plates (Falcon 3072) in a humidified atmosphere of 95% air and 5% CO,.
Stromal layers were set up in flat-bottomed microtiter plates (Costar, Badhoevedorp, The Netherlands) as previously de~cribed.'~ In brief, 106 bone marrow cells were plated in 0.2 mL of culture medium consisting of a-medium supplemented with 10% selected fetal calf serum (GIBCO), 10% horse serum (Boehringer, Mannheim, Germany), 0.5 mg/mL human transferrin (Hoechst-Behring, Amsterdam, The Netherlands), mol/L hydrocortisone sodium succinate (Sigma, St Louis, MO), and mol/L p-mercaptoethanol (Merck, Amsterdam, The Netherlands). After 10 to 11 days of culture at 33"C, 10% CO,, the cells were exposed to a dose of 20 Gy gamma radiation to eliminate hematopoietic activity. One day later the medium was changed and cultures were maintained at 33T, 10% CO, with a complete medium change per week. Before stimulation with IL-3 or IL-1 the stromal layers were washed repeatedly to eliminate serum. They were then further incubated for 48 hours at 37°C and 5% CO, in serum-free Dulbecco's modified Eagle's medium (DMEM) in the presence of optimal cytokine concentrations.
In several experiments, and particularly before cell sorting, bone marrow cells were fractionated on a Ficoll gradient, as previously described.n Briefly, the gradient was prepared from Ficoll 400 (Pharmacia Fine Chemicals, Uppsala, Sweden) at concentrations of IO%, 14.6%, 16.1%, 17.7%, 19.2%, and 23% (wt/wt) in 0.1 mol/L sodium phosphate (pH 7.4). Bone marrow cells (2 to 3 x 108) were layered on top of the gradient (1.2 mWlayer) and centrifuged for 30 minutes at 23,500g at 4°C. Layer 0 was defined as the interphase between culture medium and 10% Ficoll, and subsequent interphases were numbered sequentially. Cells were recovered from the different layers and washed three times in HBSS. They were then plated in microtiter wells at a concentration of lo6 cells/mL (layers 2 + 3 and 4) or 5 x lo6 cells/mL (layers 5 and 6). Kinetics of IL-6 production in response to IL-3 were established for each cell fraction. Cells from layers 2 + 3 that are on the average fivefold to 10-fold enriched for hematopoietic precursors" were used for cell sorting.
Labeling with monoclonal antibody (MoAb) ER-MP 20 or Rh 123.
Immunofluorescence labeling was performed with the MoAb ER-MP 20 recognizing monocytes and granulocytic cells, kindly provided by P. Leenen. Pelleted total bone marrow cells (5 x lo') were resuspended in 500 pL of hybridoma supernatant containing the MoAb and incubated for 30 minutes on ice, as reported before.z After three washings in DMEM, the cells were exposed for a further 30 minutes to the second antibody, a rabbit antirat IgG-fluorescein isothiocyanate (FITC) (Cappel, Malvem, PA) diluted 100-fold in DMEM supplemented with 2% normal mouse serum. After a 40-fold dilution (2.5 x 106/mL) the cells were proceeded for fluorescence-activated cell sorter (FACS) (see Results). Rh staining was performed on 3 X lo6 low density bone marrow cells/mL in DMEM containing 0.1 pg/mL Rh dye (Eastman Kodak, Rochester, NY) as already described?' To remove the excess of Rh not incorporated into the mitochondriae, the cells were incubated for another 30 minutes in DMEM at 37°C. Finally, they were washed twice in DMEM and resuspended (3 X 106/mL) in PBS with 0.4% bovine serum albumin (BSA Sigma, St Louis, MO).
Analysis 
Discontinuous Ficoll gradient.
Sorting of bone marrow cells. directly on the basis of forward and perpendicular light scatter (FLSPLS) in preselected areas meeting the criteria of lymphocyte, blast, low and high PLS granulocyte window (see Results) that were set using total bone marrow cells as a standard. Fluorescenceactivated sorting was then performed on the basis of Rh fluorescence inside the blast and low PLS granulocyte windows. Total and fractionated bone marrow cells were incubated for 24 or 48 hours at appropriate concentrations with optimal amounts of IL-3 (5 ng/mL). Cell-free supernatants were then removed and stored at -20°C until IL-6 assay. Total colony-forming units (CFU-C) were quantified in the different populations in a semisolid (0.8% methylcellulose, Methocel AP4 Premium; Dow Chemical) culture medium (a-modification of Dulbecco's minimum essential medium) at 37°C and 5% CO,. The cultures contained 20% Con A-stimulated mouse spleen-conditioned medium, 10% horse serum (Boehringer) and 1% BSA. One thousand to 10' cells were plated per dish. Total colonies, comprising mainly granulocytes, macrophages, or both granulocytes and macrophages were scored on day 7. The CFU-spleen (CFU-S) day 12 content of cell suspensions was determined by injecting appropriate dilutions into the lateral tail vein of lethally irradiated mice. The cell numbers injected were estimated from previous experiments to give between zero to six surface colonies on day 12. Marrow repopulating activity (MRA [CFU-C]) was determined by assessing the number of CFU-C generated over a 13-day period in femural bone marrow of lethally irradiated mice following intravenous injection of sorted cells. Data were corrected for any endogeneous CFU-C regrowth in control irradiated mice and expressed as the number of colonies per femur equivalent per lo5 cells injected." Differential counts of unfractionated or sorted bone marrow cells were performed by standard May-Griinwald-Giemsa staining.
IL-6 was determined as described before,z6 with minor modifications. In brief, B9 hybridoma cells, kindly provided by L. Aarden (Central Laboratory of the Netherlands Red Cross Blood Transfusion Service, Amsterdam, The Netherlands) were plated in flat-bottomed microtiter wells at a concentration of 5 X 103 cells per well in 100 pL of Iscove's modified Dulbecco's medium containing 5% fetal calf serum and 50 pgimL gentamycin. Samples were titrated in two-fold dilutions starting from appropriate concentrations. After a 3-day incubation, 10 pL of 3 4 4 3 dimethylthiazol 2-y1)-2,5 diphenyltetrazolium bromide ( M W ; Sigma) in PBS (5 mg/mL) was added per well. Four hours later the dark blue crystals of formazan formed in the cells were dissolved in 150 pL of 0.04 mol/L HCI in isopropanol per well. The intensity of the coloration read on a Dynatech MR microelisa reader (Marnes-laCoquette, France), using a test wavelength of 570 nm and a reference wavelength of 630 nm, is directly proportional to the number of viable cells per well. IL-6 was quantified in relation to a standard preparation from P388 D1-conditioned medium containing saturating amounts of the factor. One unit per milliliter is the concentration that leads to half-maximal cell proliferation in the assay. Several culture supernatants have also been tested on the IL-&dependent 7TD1 hybridoma cell line, with results that were similar to those obtained in the B9 assay. The biologic activity of these samples is completely neutralized by the rat anti-IL-6 MoAb 6B4. The MoAb as well as the 7TD1 hybridoma cell line were kindly provided by J. Van Snick (Ludwig Institute for Cancer Research, Brussels, Belgium.)
The technique used was based on the work of Lawrence and Singel' and Cox et a1,2" with some modifications. In brief, low density cells from the Ficoll gradient, previously incubated for 4 hours with 5 ng/mL of mrIL-3 or culture medium, were cytocentrifuged and immediately fixed in 4% paraformaldehyde in PBS for 3 minutes at room temperature. Preparations were Incubations with rIL-3; colony and repopulation assays.
IL-6 assay.
In situ hybndization. . The IL-6 probe used was a 700-bp insert corresponding to the complete coding region of murine IL-6 cDNA cloned into the pGEM4 plasmid (Promega Biotec, Madison, WI) using the polymerase chain reaction, according to the sequence previously d e s~r i b e d .~~ Recombinant pGEM4-IL-6 was controlled by the dideoxy sequencing method using denatured plasmid template.M In previous Northern blot analyses performed with this probe, IL-6 mRNA was detectable as a single band of about 1.3 kb in virus-stimulated murine fibroblasts (data not shown). The murine p-actin cDNA (a generous gift from Dr F. Dautry, Villejuif, France) cloned into a transcription vector served as a positive control, whereas a 1.37-kb h phage DNA fragment cloned into a pGEM vector provided the negative control. Run-off transcripts of appropriate linearized plasmid were synthetized using either T7 or T3 RNA polymerase in a reaction medium containing 60 KCi [ C~~~S ] -U T P (1, 200 Ci/mmol; Amersham, Les Ulis, France) according to the manufacturer's instructions (Promega Biotec), except that unlabeled UTP was omitted to synthetize RNA probes with a specific activity of lo9 cpm/p,g. Their fragment length was adjusted to a mass average of approximately 100 to 150 bases by limited alkaline hydrolysisz7 and they were of similar specific activity and size. RNA probes were ethanol-precipitated with yeast tRNA and salmon sperm DNA and washed with 70% ethanol. The dried pellets were resuspended in the hybridization buffer to give final concentrations of 50% deionized fonnamide, 0.3 mol/L NaCl, 20 mmoVL Tris-HCI (pH 8), 0.5 mmol/L EDTA, 1X Denhardt's, 10% dextran sulfate, 20 m m o n DTT, 500 FdmL yeast tRNA, 1 mg/mL salmon sperm DNA, and lo8 cpm/mLof the RNA probe. The slides were post-fixed in 2% paraformaldehyde/l% glutaraldehyde in PBS for 7 minutes, washed in PBS, acetylated in 0.25% acetic anhydride in 0.1 moUL triethanolamine buffer (pH 8) for 10 minutes, washed in PBS, dehydrated in ethanol, and air dried. The hybridization mixture was denaturated, applied to slides, and covered with parafilm. Hybridization was performed at 50°C for 15 hours in a humidified chamber. The subsequent washing procedures were all performed in the presence of 10 mmol/L D l T when not otherwise specified. Slides were washed successively at 52°C for 15 minutes in (1) 2X SSC; (2) 50% formamide, 2X SSC; (3) 2X SSC, followed by a RNase A digest (10 p g h L in 2X SSC) for 10 minutes at 37°C in the absence of DIT. After a second set of washing in 50% formamide, 2X SSC at 52°C for 5 minutes, the slides were successively washed at 52°C for 5 minutes in (1) 2X SSC, (2) 1X SSC, (3) 0.5X SSC, 14) 0.1X SSC, and dehydrated in ethanol. For autoradiography, the slides were dried and coated with NTB2 emulsion (Eastman Kodak). After exposure, the slides were developed in Dektol (Eastman Kodak), fixed in Unifix (Eastman Kodak), and stained with May-Grunwald-Giemsa.
RESULTS
IL-3induced IL-6 production in different murine organs. As resumed in Fig 1, bone marrow cells are by far the best targets for IL-3 in terms of IL-6 production among the populations tested. Splenocytes also respond to the growth factor, though to a much lesser extent, in agreement with the lower incidence of progenitors in spleen. The amounts of IL-6 generated by peritoneal adherent cells are too low to ascribe its production by bone marrow or even spleen cells in response to IL-3 entirely to the presence of macrophages in these organs. Lymph node and thymus cells (the latter are not represented here) do not consistently secrete this cytokine, whatever the growth factor concentrations used.
As shown in Fig 2A, bone marrow IL-6 production promoted by IL-3 is dose-dependent, reaching a plateau between 5 and 10 ng/mL (80 to 160 U/mL, as evaluated on the IL-3-dependent cell line FDCP-2). For comparison, hrIL-lp at saturating amounts (10 ng/mL) is a much less effective stimulus of this biologic activity in bone marrow of incubation; means ? SEM from five different experiments). The kinetics established at optimal doses of IL-3 ( Fig 2B) show that the onset of IL-6 generation by bone marrow cells is rather rapid, with a significant increase after 5 hours continuing up to 72 hours.
Distribution of IL-6-producing cells in different layers of a discontinuous Ficoll gradient. The time course of IL-6 production induced by IL-3 has been determined for each cell fraction in the different layers of the density gradient, excepting layer 1 (containing only around 0.1% of total cells and few hematopoietic progenitor^).'^ Kinetics are very similar to those observed with total bone marrow, though the maximum in the less dense layers is attained earlier, within 24 hours (data not shown). For this reason, Fig 3 represents the results at this time point. It is clearly apparent that the cells responding to IL-3 by increased IL-6 production are concentrated in layers 2 + 3, containing 2%
to 5% of the total C57BL/6 bone marrow population. They copurify with early hematopoietic progenitors, such as CFU-S day 8, CFU-C, and mast cell precursors, we have previously r e p~r t e d~" '~ to be enriched in this fraction. In addition, erythrocytes have been completely eliminated from layers 2 + 3 and, as shown by differential counts in the different density fractions represented in Table 1 , granulocyte, late granulocyte precursor, and erythroblast compartments are partly depleted. Conversely, this fraction is about threefold enriched in undifferentiated blasts. The frequency of monocytes and lymphocytes is less than two times higher than in unfractionated bone marrow.
The MoAb ER-MP 20 recognizes monocytes with a high affinity and granulocytes or their late precursors with a lower affinity. These subsets (5% and 40%, respectively, of the total bone marrow in the particular experiment reported here) can be easily separated from the remaining 55% unlabeled cells. After a 24-hour exposure to IL-3, the cell fraction that is not recognized by the MoAb produces over two times more IL-6 than unsorted cells (290 ? 10.5 versus 119 2 5.9 U/106 cells; means 2 SD of triplicate determinations), while neither sorted monocytes nor granulocytes respond consistently to the growth factor, indicating that they are not responsible for this biologic activity.
Stromal cells incubated for 48 hours in serum-free conditions with optimal IL-3 doses produce low IL-6 levels (18.0 2 5.1 U/106 initially plated bone marrow cells versus 2.5 ? 0.5 U/106 cells in control cultures; means k SD from triplicate determinations). In contrast, these cells respond well to IL-1 (235 2 28.9 U/106 initially plated cells; mean ? SD from triplicate determinations) that has been previously reported to act as an effective stimulus of this population in human3' and mouse."
Light scatterproperties of bone marrow cells producing IL-6 in response to IL-3. The dot display of FLS/PLS in Fig 4 illustrates how the thresholds for the sorting windows, hereafter referred to as ''lymphocyte,'' "blast," high and low PLS "granulocyte" window, have been selected. It should be noted that these designations only indicate a high frequency of such cells in the gated area but do not exclude the presence of other cells in these windows. The average percentage of cells from layers 2 + 3 of the Ficoll gradient responding to these criteria is indicated. Figure 5A represents the IL-6 levels induced by IL-3 in the sorted fractions. As already suggested by the lack of responder cells among thymocytes and lymph node cells, a major contribution of T cells to this biologic activity can be excluded because the light scatter area where lymphocytes are most frequent (lymphocyte window) is depleted for IL-&producing cells. The same conclusion applies to B cells that are also preferentially located in this area. The bulk of cells involved in IL-6 production is generally selected in the low PLS granulocyte window, the population with higher PLS light scatter characteristics containing less responder cells. Their relative distribution between low PLS granulocyte and blast window depends on the efficiency of the prepurification step. Indeed, the more granulocytes remain in layers 2 + 3, the more the responder cell frequency in the low PLS granulocyte window will decrease, while IL-6 production in the blast window that contains less granulocytes becomes accordingly higher. Differential counts have established that, compared with Ficoll-fractionated bone marrow, the low PLS granulocyte window is on the average twofold enriched for unidentified blast cells and contains slightly more (1.5-fold) morphologically recognizible immature myeloid cells (promyelocytes, myelocytes, and metamyelocytes) than the low density population. Thirty percent to 50% of this subset represent differentiated cells, with a majority of granulocytes (20% to 40%). The blast window contains about two to three times more unidentified blast cells than the low density population and is also around twofold enriched for small "lymphocyte-like" cells (40%). In contrast, the incidence of late myeloid precursors is five to 10 times lower than in Ficollfractionated bone marrow. Mature granulocytes and monocytes represent only 2% and 6%, respectively, of this subset. The distribution of CFU-C over these windows in one representative experiment is shown in Fig 5B. It is broader than that of IL-&producing cells, suggesting that only a part of the cells forming colonies in the methylcellulose assay is involved. Characterization of IL-6-producing cells on the basis of Rh labeling. After Rh staining, the cells from Ficoll layers 2 + 3 gated for the blast or low PLS granulocyte window (35% and 12% of low density cells, respectively) were further analyzed on the basis of their fluorescence intensity. In the two light scatter areas, cells were sorted into four equally large fractions differing in Rh retention. Their capacity to produce IL-6 in response to IL-3 (Fig 6) was compared with the incidence of CFU-C, CFU-S day 12, and M U [CFU-C] in these subsets represented in Table 2 . Quiescent stem cells with long-term in vivo reconstituting activity (MRA [CFU-C]) are highly enriched in the Rh-dull fraction of the blast window and, to a lesser extent, in the corresponding fraction of the low PLS granulocyte window ( Table 2) secrete the factor increases with increasing Rh retention, reaching a maximum in the Rh+ + + subset of the low PLS granulocyte window, where this biologic activity is about 40-fold enhanced over that of unsorted bone marrow cells. This distribution of IL-&producing cells in the different fractions is very similar to that of CFU-C represented in Table 2 . There is no correlation between IL-3-induced IL-6 Cells from Ficoll layers 2 + 3 were gated for the blast or low PLS granulocyte window (see Fig 2) . containing 35% and 12% of all cells, respectively. They were sorted into four equally large fractions differing in rhodamine retention. Results are expressed as means 2 SEM from three separate experiments, excepting the data for day 12 CFU-S and MRA[CFU-C] in the low PLS granulocyte window corresponding to one experiment. Abbreviation: ND, not determined.
production and CFU-S day 12 frequencies that are highest in the Rh-bright fraction of the blast window. Differential counts in cell subsets sorted from either blast or low PLS granulocyte window according to their fluorescence intensity after Rh staining show a gradual increase in the percentage of unidentified blast cells from Rh-dull to Rh-bright fractions. Indeed, this cell type is almost completely lacking in the subpopulations with very low Rh retention, while it represents 82% and 45% of the most fluorescent cells of the blast and low PLS granulocyte window, respectively. This latter area is also enriched for immature myeloid cells (promyelocytes, myelocytes, and metamyelocytes: 29%), in contrast with the corresponding population in the blast window that contains only 1% to 2% of such cells. A small percentage of monocytes and lymphocytes (5% to 10% each) is present in the two highly fluorescent subsets together with about 5% nucleated erythroid cells in the Rh-bright low PLS granulocyte fraction. Band and segmented granulocytes are almost exclusively selected in the Rh-dull fractions (81% of the Rh-low PLS granulocyte window and 3% of the blast window) that do not respond to IL-3 in terms of IL-6 production. Small "lymphocyte-like" cells are predominant in the Rh-dull blast window (85%) that is most enriched for marrow repopulating activity, while this cell type is depleted in the corresponding fraction of the low PLS granulocyte window
Evidence for IL-6 mRNA expression by low density cells. In situ hybridization experiments were performed on Ficollfractionated bone marrow cells after 4 hours of incubation in culture medium with or without IL-3. The specificity of hybridization was assessed by the use of the negative A control probe (Fig 7C) , ribonuclease treatment of some cell preparations and the great heterogeneity of cell labeling. Background signal was estimated to be less than 10 silver grains per cell. The integrity of the mRNA was verified by a positive control using an actin probe. IL-3 induces a clear increase in the IL-6 mRNA levels expressed by unstimulated cells (Fig 7A and B) . A heavily and a more moderately labeled group of positive cells can be distinguished (> 100 and 20 to 100 grains/cell, respectively). The cells belonging to the first category are relatively more frequent after stimulation (about 30 of 100 labeled cells after IL-3 stimulation) than in the control, where they represent 15% of the positive population (Fig 8) . As illustrated in Fig 7, several cell types express IL-6 mRNA, such as small blast-like cells (about 25% of labeled cells represented in Fig 7D) and large myeloid cells with "kidney"-or "doughnut"-shaped nuclei shown in Fig 7E and F (about 75% of labeled cells in response to IL-3). Some positive cells cannot be ascribed to either of these categories because of their heavy label.
(2% to 5%). DISCUSSION IL-6 is produced at variable levels by a number of cell types depending on the stimulus used for its induction.33 Its wide distribution may be explained by the fact that, besides its major systemic effects as a hepatocyte stimulating factor,34 it plays also a role in local events in different parts of the body. In particular, several recent reports have stressed the important regulatory functions of IL-6 in combination with growth factors during It is generally assumed that in this context the cytokine is released by stimulated stromal cells to exert its action in the hematopoietic en~ironment.''~~~ The present study provides evidence that bone marrowderived IL-6 generated in response to IL-3 is mainly due to immature cells. The contribution of stromal cells to this phenomenon is negligible, conversely to their major role in IL-1-induced IL-6 production. It should be noted that IL-6 levels spontaneously released by stromal layers in vitro may vary considerably according to culture conditions and especially serum concentrations. They are generally quite low or undetectable in serum-free cultures and their increase over control values after exposure to IL-3 cannot account for the striking IC-6 secretion by bone marrow cells. A similar conclusion can be drawn from the data obtained with peritoneal macrophages. Several lines of evidence have allowed us to exclude likewise the participation of other mature cells or late morphologically identifiable precursors in our phenomenon. A first argument against the involvement of granulocytes arose from the observation that the enrichment for IL-6-producing cells in the less dense fractions was accompanied by their depletion. This finding was confirmed by the following observations: (1) granulocytes labeled by the ER-MP 20 MoAb do not consistently produce IL-6 in response to IL-3; (2) the Rh-dull population from the low PLS granulocyte window that is mainly composed of this cell type does not respond to IL-3; and (3) morphologically identifiable granulocytes or their late precursors are not labeled by the IL-6 probe after in situ hybridization. In addition, the participation of B and T lymphocytes could be ruled out both indirectly, by the fact that thymocytes and lymph node cells cannot be stimulated by IL-3 to produce IL-6, and directly, on the basis of FLSPLS sorting from the lymphocyte window and in situ hybridization. Finally, the involvement of erythroblasts is also highly improbable, because of their depletion from layers 2 + 3 of the density gradient.
Having thus discarded a major contribution of more mature hematopoietic cells to IL-3-induced IL-6 production, we have further characterized the progenitors involved by FLS/PLS and fluorescence-activated cell sorting. These experiments were performed on Ficoll-fractionated low density cells that have been previously shown to be enriched for CFU-S day 8, CFU-C, and mast cell precursors.22 Indeed, the fact that these progenitors actually copurify with IL-&producing cells in this pre-enrichment step initially suggested to us that immature cells could be responsible for this biologic activity. This finding is also in agreement with a previous report by Lotem et al demonstrating that IL-6 production in response to hematopoietic growth factors increases with progenitor enrichment. 18 The relatively high light scatter characteristics of IL-6-producing cells concentrated in the blast and particularly in the low PLS granulocyte window lend further support to a major contribution of immature cells to this phenomenon.
The cell population located in these light scatter areas can be further distinguished on the basis of Rh-123 retention, using the low uptake of this dye by stem cells with bone marrow repopulating activity as a means to separate them from other progenitor^.^^^^^ It is clear that the most primitive stem cells isolated by this method are not involved in our phenomenon. Conversely, IL-6 production by cell populations selected within the blast or low PLS granulocyte window increases with the increasing ability of these cells to retain Rh. Previous reports have established that the fluorescence intensity of labeled cells depends on the number and activity of their mitochondriae and is linked to the cell cycle tatu us.^^.^" For this reason, the MRA cells that are in Go do not take up the Rh and can thus be easily separated from other hematopoietic progenitors already engaged in the process of differentiation. The Rh-bright fractions still comprise various progenitors, including, in particular, CFU-S and progenitors forming macrophage/ granulocyte colonies in methylcellulose. Our results argue in favor of a predominant implication of partially committed progenitors in IL-3-induced IL-6 secretion. Indeed, the incidence of IL-&producing cells is generally highest in the low PLS granulocyte window, despite the fact that primitive blast cells are more frequent in the blast cell window. Furthermore, the distribution of the IL-3 responder cells in terms of IL-6 production over the FLS/PLS light scatter windows is rather similar to that of progenitors forming colonies in methylcellulose. There is also a good correlation between these activities in the Rh fractions of the blast and low PLS granulocyte window, with a maximum in the Rh-bright subset of the latter population, while the highest frequency of CFU-S day 12 occurs in the corresponding fraction of the blast window. This latter finding is in accordance with the distribution of blast cells in these areas that are preferentially selected in the population defined by the lower PLS, while early myeloid progenitors are most frequent in the adjacent sorting window. Furthermore, the recent demonstration of IL-6 production by several myeloid IL-3-dependent cell lines fits into the conclusion that cells with a restricted differentiation potential are mainly involved in this phen~menon.~'
These arguments in support of a possible identity between IL-&producing cells and progenitors forming granulocyte and/or macrophages in methylcellulose are further corroborated by the morphology of the cells expressing IL-6 mRNA. Indeed, the majority of the labeled cells possess either "doughnut"-or "kidney"-shaped nuclei. This morphology corresponds to precursors of the myeloid lineage, such as promyelocytes and myelocytes, with a "monocytelike" appearance for some labeled cells. Yet, a major participation of monocytes in IL-3-induced IL-6 production is highly improbable because neither monocytes sorted on the basis of their affinity for the MoAb ER-MP 20 nor Rh-dull cells express this biologic activity, despite the higher incidence of monocytes in this latter population relative to Rh-bright cells (unpublished data). About 25% of the labeled cells cannot be described by morphologic criteria, belonging apparently to a more immature blast-like cell type.
In situ hybridization has shown heterogeneity in the intensity of IL-6 mRNA expression, the most heavily labeled cells being of blast-like appearance. This observation is consistent with the hypothesis that hematopoietic progenitors may acquire the ability to produce IL-6 in response to IL-3 while starting their differentiation process and may lose it progressively during subsequent maturation stages. Thus, the immature cell population responsible for this biologic activity might comprise a relatively large spectrum of precursors, in particular those giving rise to granulocyte/macrophage colonies that copurify with IL-6-producing cells during the sorting procedures used herein. This finding does not exclude the participation of other progenitor subsets in IL-3-induced IL-6 production, in particular burst-forming unit-erythroid (BFU-E) and uncommitted mast cell precursors. In contrast, lineagecommitted mast cells isolated from gut mucosa4* secrete IL-6 neither spontaneously nor in response to IL-3 (unpublished data). Thus, the possible overlap between a predominant IL-&producing population belonging probably to the CFU-C subset and other more or less differentiated progenitors exists only to a certain extent because lineagecommitted mast cells as well as late morphologically recognizable erythroid precursors and immature granulocytes or macrophages labeled by the ER-MP 20 MoAb lack this biologic activity.
In conclusion, our findings demonstrate that murine hematopoietic progenitors, and, more particularly, those giving rise to the macrophage/granulocyte lineage, can produce IL-6 in response to IL-3. A tentative explanation of this phenomenon might be that in emergency situations leading to endogenous IL-3 production," immature cells, while differentiating in response to the growth factor, might at the same time provide the signal activating their quiescent progenitors. IL-6 has been claimed to possess such an activity because in combination with IL-3 it enables these cells to leave Go earlier, while IL-3 alone supports the growth of blast cell colony-forming cells only once they have emerged from the quiescent state." On the other hand, the IL-6 thus generated may also act on the progeny of the producer cells because it has been reported that in combination with the colony-stimulating factors IL-6 is implicated in the differentiation of a variety of hematopoietic lineage^.^'."
